PT34 A Transitional Reimbursement Mechanism for New Medicinal Products Addressing High Unmet Clinical Need in Gree Proposal for a Medicines Innovation Fund
Abstract
Authors
Kyriakos Souliotis Christos Tsakalogiannis Aris Angelis